A cyclic fluctuation model for 24-h ambulatory blood pressure monitoring in Chinese patients with mild to moderate hypertension

Abstract

Aim:The conventional method for analyzing 24-h ambulatory blood pressure monitoring (24-h ABPM) is insufficient to deal with the large amount of data collected. The aim of this study was to develop a novel cyclic fluctuation model for 24-h ABPM in Chinese patients with mild to moderate hypertension. Methods: The data were obtained from 4 independent antihypertensive drug clinical trials in Chinese patients with mild to moderate hypertension. The measurements of 24-h ABPM at the end of the placebo run-in period in study 1 were used to develop the cyclic fluctuation model. After evaluated, the structural model was used to analyze the measurements in the other 3 studies. Models were fitted using NONMEM software. Results: The cyclic fluctuation model, which consisted of 2 cosine functions with fixed-effect parameters for rhythm-adjusted 24-h mean blood pressure, amplitude and phase shift, successfully described the blood pressure measurements of study 1. Model robustness was validated by the bootstrap method. The measurements in the other 3 studies were well described by the same structural model. Moreover, the parameters from all the 4 studies were very similar. Visual predictive checks demonstrated that the cyclic fluctuation model could predict the blood pressure fluctuations in the 4 studies. Conclusion: The cyclic fluctuation model for 24-h ABPM deepens our understanding of blood pressure variability, which will be beneficial for drug development and individual therapy in hypertensive patients.

Characterization of Anti-Cancer Drug Materials Loaded Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) Microspheres for Drug Delivery System in Biochemical Material System

“…After a fast release during the first 24 h of assay, 54.28% of CsA and 49.76% of 5-FU were released from PHB microspheres. Similar results by Wang [28] for PHB encapsulation of levonorgestrol were obtained. When microspheres were prepared from PHBHHx, a significant change in the amount of released could be observed.…”

Pharmacochemistry and integrated pharmacokinetics of six alkaloids after oral administration of Huang-Lian-Jie-Du-Tang decoction

“…As well-known, the alkaloids have a broad spectrum of strong biological activities, but it is generally assumed that quaternary amine type isoquinoline alkaloids are poorly absorbed by gastrointestinal tract such as BB, with up to 5% bioavailability [10,11] and the metabolism occurs in the liver in vivo [12]. In the present study, seven alkaloids from the HLJDT decoction could be detected in the dosed plasma, suggesting that all these alkaloids can be absorbed by gastrointestinal tract into the blood circulation.…”

Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors

“…Seven circadian blood pressure models 28 , 29 , 30 , 31 , 32 , 33 , 34 and four exposure–response models 9 , 11 , 34 , 35 were identified. The model by Trocóniz et al 30 was selected (Table S1 ) over other identified circadian models for different reasons (Table S2 ).…”

“…Nonlinear mixed‐effects models have been developed as statistical tools that incorporate biological features to understand variability in pharmacological and physiological endpoints 26,27 . Previous efforts have given rise to blood pressure models that capture the various deterministic and stochastic aspects related to blood pressure changes over time 28–34 . In addition, multiple exposure–response models have become available, linking drug TKI exposure to longitudinal changes in blood pressure 9,11,34–36 .…”

“… 26 , 27 Previous efforts have given rise to blood pressure models that capture the various deterministic and stochastic aspects related to blood pressure changes over time. 28 , 29 , 30 , 31 , 32 , 33 , 34 In addition, multiple exposure–response models have become available, linking drug TKI exposure to longitudinal changes in blood pressure. 9 , 11 , 34 , 35 , 36 However, adaptation of these models requires a degree of expertise and clinical implementation might be hampered.…”